Eli Lilly Gets CDSCO Panel Nod to Study Lepodisiran Dr. Divya Colin25 April 2024 6:00 PM ISTNew Delhi: The drug major Eli Lilly has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Lupin Digital Health's Lyfe Platform gets Class C Medical Device license from CDSCO Ruchika Sharma25 April 2024 4:23 PM ISTMumbai: Lupin Digital Health, India's evidence-based cardiology Digital Therapeutics (DTx) platform, has announced that its Lyfe platform has...
GSK Gets CDSCO Panel Nod to Study antimalarial drug Tafenoquine Dr. Divya Colin24 April 2024 6:00 PM ISTNew Delhi: The pharmaceutical major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Zydus Lifesciences Gets CDSCO Panel nod to study Bivalent Typhoid and Paratyphoid A Conjugate Vaccine Dr. Divya Colin24 April 2024 5:15 PM ISTNew Delhi: Reviewing the Phase I clinical trial protocol of the vaccine Bivalent Typhoid and Paratyphoid A Conjugate Vaccine, the Subject Expert...
Zydus Gets CDSCO Panel Nod To Manufacture Market Letermovir 240 mg, 480 mg Tablet Dr. Divya Colin23 April 2024 6:00 PM ISTNew Delhi: The drug major Zydus has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Submit post-marketing safety data of Belumosudil in Chronic graft versus host disease: CDSCO Panel Tells Sanofi Dr. Divya Colin21 April 2024 6:00 PM ISTNew Delhi: Responding to the proposal presented by the drug major Sanofi to import and market Belumosudil tablets 200 mg, the Subject Expert Committee...
Novartis Gets CDSCO Panel Nod to Study anti-cancer drug Ribociclib Dr. Divya Colin21 April 2024 5:30 PM ISTNew Delhi: The drug major Novartis has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Approves Eli Lilly's protocol amendment proposal for Adjuvant Imlunestrant vs Standard Adjuvant study Dr. Divya Colin21 April 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major Eli...
Novo Nordisk Gets CDSCO Panel Nod to Study new medicine NNC0519-0130 Dr. Divya Colin21 April 2024 5:00 PM ISTNew Delhi: The drug major Novo Nordisk has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Dr Reddy's Laboratories gets CDSCO Panel Nod To Import and Market Toripalimab 240mg solution for infusion Dr. Divya Colin20 April 2024 6:00 PM ISTNew Delhi: Noting an unmet medical need for recurrent locally advanced/metastatic nasopharyngeal carcinoma (RM-NPC) in India, the Subject Expert...
CDSCO approves Abbott's proposal for Protocol Amendment of Triamcinolone Hexacetonide study Dr. Divya Colin20 April 2024 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the protocol...
Conduct Phase III clinical trial: CDSCO Panel Tells BDR Pharmaceutical on Anti-cancer Drug Abiraterone Acetate Dr. Divya Colin20 April 2024 5:45 PM ISTNew Delhi: Reviewing the justification for waiver of the Phase III clinical trial of the anti-cancer drug Abiraterone Acetate presented by BDR...
